期刊文献+

PARP-1体外活性测定方法的建立及其应用

Establishment and Application of Enzymatic Assay for Poly(ADP-Ribose) Polymerase-1
下载PDF
导出
摘要 建立PARP-1的体外活性测定方法并对84个具有潜在PARP抑制活性的化合物进行筛选。从Sf9昆虫细胞中提取酶液,以NAD+为底物,DNA为激活剂,建立PARP-1的活性测定方法;以高通量技术参数评价此方法,用已知PARP抑制剂进行验证,并以此方法进行PARP抑制剂的筛选。结果显示,确定的酶促反应体系为:12.5 nmol/L NAD+,15μg/m L DNA,6.25×10-4U PARP-1。评价Z'因子为0.76,S/B值为3.58。基于此模型筛出47个化合物在浓度7.4μmol/L时对PARP-1的抑制率达到60%以上。表明所建立的PARP-1活性测定方法,适用于PARP-1抑制剂的高通量筛选。 To establish an enzymatic assay for poly(ADP-ribose) polymerase-1 and screen PARP inhibitors from 84 potential compounds.Crude PARP-1 was extracted from Sf9 insect cells.With nicked DNA as activator,PARP-1 was used to catalyze the hydrolysis of the substrate NAD+,the RFU value measured from the remaining NAD^+was used to evaluate the activity of PARP-1 or efficiency of PARP inhibitors.A 96-microwell screening method was set up by optimizing the reaction system.The screening method was assessed with high throughput index,such as Z' factor,signal to back ground(S/B) and validated by well-known PARP inhibitors such as PHE,DPQ and AZD2281.84 compounds were assayed for PARP inhibition through the established method.The enzymatic reaction system was optimized as:12.5 nmol/L NAD^+,15 μg/m L DNA,6.25 ×10^-4U PARP-1.The Z' factor is 0.76,S/B is 3.58 and the IC50 of PHE,DPQ and AZD2281 is 562.4 nmol/L,369.6 nmol/L and 6.8 nmol/L.There are 47 compounds showed 60% or more PARP-1 inhibition efficiency at the concentration of 7.4 μmol/L.An enzymatic assay of PARP-1 was successfully established.It can be effectively applied to high-throughput screening for PARP inhibitors.
机构地区 江南大学药学院
出处 《食品与生物技术学报》 CAS CSCD 北大核心 2015年第3期324-329,共6页 Journal of Food Science and Biotechnology
关键词 多聚二磷酸腺苷核糖基聚合酶-1 活性测定 抑制剂 高通量筛选 poly(ADP-ribose) polymerase-1 enzymatic assay inhibitors high-throughput screening
  • 相关文献

参考文献16

  • 1Woodhouse B C,Dianov G L.Poly ADP-ribose polymerase-1:An international molecule of mystery[J].DNA Repair(Amst),2008,7(7):1077-1086.
  • 2Jagtap P,Szabo C.Poly(ADP-ribose)polymerase and the therapeutic effects of its inhibitors[J].Nat Rev Drug Discov,2005,4(5):421-440.
  • 3Abd Elmageed Z Y,Naura A S,Errami Y,et al.The poly(ADP-ribose)polymerases(PARPs):New roles in intracellular transport[J].Cell Signal,2012,24(1):1-8.
  • 4Peralta-Leal A,Rodriguez-Vargas J M,Aguilar-Quesada R,et al.PARP inhibitors:New partners in the therapy of cancer and inflammatory diseases[J].Free Radic Biol Med,2009,47(1):13-26.
  • 5Lee J M,Ledermann J A,Kohn E C.PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-Iike malignancies[J].Ann 0ncol,2014,25(1):32-40.
  • 6Plummer R,Jones C,Middleton M,et al.Phase I study of the poly(ADP-ribose)polymerase inhibitor,AG014699,in combination with temozolomide in patients with advanced solid tumors[J].Clin Cancer Res,2008,14(23):7917-7923.
  • 7Ferraris D V.Evolution of poly(ADP-ribose)polymerase-1(PARP-1)inhibitors:From concept to clinic[J].J Med Chem,2010,53(12):4561-4584.
  • 8柳军,张陆勇.聚腺苷二磷酸核糖聚合酶-1抑制剂高通量筛选模型[J].中国药理学通报,2007,23(1):124-127. 被引量:7
  • 9周海燕,马军,杨雪丽,龚笑海,李秋萍,金坚.hPARP1酶在杆状病毒/昆虫细胞中的高表达及快速纯化[J].生物工程学报,2013,29(7):998-1005. 被引量:3
  • 10Putt K S,Hergenrother P J.An enzymatic assay for poly(ADP-ribose)polymerase-1(PARP-1)via the chemical quantitation of NAD(+):Application to the high-throughput screening of small molecules as potential inhibitors[J].Anal Biochem,2004,326(1):78-86.

二级参考文献34

  • 1韩光亮,尚念勇,杜冠华.酪氨酸蛋白激酶抑制剂的高通量筛选模型[J].中国药理学通报,2005,21(5):628-631. 被引量:17
  • 2柳军,张陆勇.聚腺苷二磷酸核糖聚合酶-1抑制剂高通量筛选模型[J].中国药理学通报,2007,23(1):124-127. 被引量:7
  • 3孙继梅,刘建华,周秀珍,张智洁,刘勇.不同配比的他唑巴坦与头孢噻肟对β内酰胺酶的稳定性[J].中国临床药理学杂志,2007,23(1):21-23. 被引量:2
  • 4柳军,牛蕤,张陆勇.糖原磷酸化酶抑制剂高通量筛选模型的建立[J].中国新药杂志,2007,16(6):447-450. 被引量:6
  • 5Southan G J,Szabo C.Poly(ADP-ribose) polymerase inhibitors[J].Curr Med Chem,2003,10(4):321-40.
  • 6Putt K S,Hergenrother P J.An enzymatic assay for poly(ADP-ribose) polymerase-1(PARP-1) via the chemical quantitation of NAD^+:application to the high-throughput screening of small molecules as potential inhibitors[J].Analyt Biochem,2004,326:78-86.
  • 7Eliasson M J L,Sampei K,Mandir A S,et al.Poly(ADP-ribose)polymerase gene disruption renders mice resistant to cerebral ischemia[J].Nat Med,1997,3:1089-95.
  • 8Takahashi K,Pieper A A,Croul S E,et al.Post-treatment with an inhibitor of.Poly(ADP-ribose)polymerase attenuates cerebral damage in focal ischemia[J].Brain Res,1999,829:46-54.
  • 9Banasik M,Komura H,Shimoyama M,et al.Specific inhibitors of Poly(ADP-ribose)syntheses and mono(ADP-ribosyl)transferase[J].J Biol Chem,1992,267:1569-75.
  • 10Suto.Substituted dihydroisoquiniolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents;selected compounds,analogs and process[P].US Patent No,5,177,075.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部